Table 1.
Country |
Reimbursement data |
Antimicrobial sales data |
|||||
---|---|---|---|---|---|---|---|
Human, community uses |
Human, hospital uses |
Human, combined community and hospital uses |
Human, community uses |
Human, hospital uses |
Human, combined community and hospital uses |
Animal uses |
|
Austria |
X |
X |
|||||
Belgium |
X |
X |
X |
||||
Bulgaria |
X |
X |
X |
||||
Croatia* |
X |
X |
|||||
Cyprus |
X |
X |
|||||
Czech Republic |
X |
X |
|||||
Denmark |
X |
X |
X |
||||
Estonia |
X |
X |
X |
||||
Finland |
X |
X |
X |
||||
France |
X |
X |
X |
||||
Germany |
X |
X |
|||||
Greece* |
X |
X |
|||||
Hungary |
X |
X |
|||||
Iceland |
X |
X |
|||||
Ireland |
X |
X |
X |
X |
|||
Italy |
X |
X |
X |
||||
Latvia |
X |
X |
X |
||||
Lithuania |
X |
X |
X |
||||
Luxembourg |
X |
X |
X |
||||
Malta* |
X |
X |
|||||
Netherlands |
X |
X |
X |
||||
Norway |
X |
X |
X |
X |
X |
||
Poland |
X |
X |
|||||
Portugal |
X |
X |
X |
X |
|||
Romania* |
X |
||||||
Slovakia |
X |
X |
X |
||||
Slovenia |
X |
X |
X |
X |
X |
||
Spain |
X |
X |
|||||
Sweden |
X |
X |
X |
||||
United Kingdom | X | X |
*No data in animals.